WASHINGTON, DC — On Friday, TechFreedom urged the Federal Trade Commissioners (FTC) not to reverse the dismissal of a lawsuit brought by FTC staff against LabMD, a small cancer testing lab that went out of business under the weight of the lawsuit, but has continued to challenge the FTC’s approach to data security with pro bono representation. In an Amicus Curiae brief, TechFreedom argues that the FTC must not ignore the most important limit that Congress has placed on the FTC’s sweeping power to prohibit business practices: that a practice must “causes or is likely to cause substantial injury.”